Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.


The purpose of this study was to determine whether the pharmacokinetics of warfarin and ciprofloxacin PR (a prolonged-release formulation of ciprofloxacin) were altered after coadministration. Eighteen healthy male volunteers were given a single oral 7.5-mg dose of warfarin, a single oral 500-mg dose of ciprofloxacin PR, or both drugs administered together… (More)


  • Presentations referencing similar topics